Blood Biomarkers of Ischemic Stroke

167Citations
Citations of this article
350Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This review provides a summary of the protein and RNA biomarkers that have been studied for the diagnosis and assessment of ischemic stroke. Many of the biomarkers identified relate to the pathophysiology of ischemic stroke, including ischemia of CNS tissue, acute thrombosis and inflammatory response. These biomarkers are summarized by their intended clinical application in ischemic stroke including diagnosis, prediction of stroke severity and outcome, and stratification of patients for stroke therapy. Among the biomarkers discussed are recent whole genome studies using RNA expression profiles to diagnose ischemic stroke and stroke etiology. Though many candidate blood based biomarkers for ischemic stroke have been identified, none are currently used in clinical practice. With further well designed study and careful validation, the development of blood biomarkers to improve the care of patients with ischemic stroke may be achieved. © 2011 The American Society for Experimental NeuroTherapeutics, Inc.

Author supplied keywords

Cite

CITATION STYLE

APA

Jickling, G. C., & Sharp, F. R. (2011, July). Blood Biomarkers of Ischemic Stroke. Neurotherapeutics. https://doi.org/10.1007/s13311-011-0050-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free